ClinicalTrials.gov – Page 46

May 18, 2026

Application for Arts-Based Social Prescribing

Conditions: Depression in Adolescence; Anxiety; Loneliness; Social Connectedness

Interventions: Behavioral: Art Pharmacy; Other: Stable treatment

Sponsors: SocialRx Inc; National Center for Complementary and Integrative Health (NCCIH); Boston College

Not yet recruiting

May 18, 2026

Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder

Conditions: Major Depression; Healthy Participants

Interventions: Device: Sham iTBS; Device: TMS; Drug: D-cycloserine; Drug: Dextromethophan; Drug: Placebo

Sponsors: Mclean Hospital; National Institute of Mental Health (NIMH)

Not yet recruiting

May 18, 2026

Deep Learning for Early Scoliosis Detection Using mmWave Radar Gait Data

Conditions: Scoliosis Idiopathic Adolescent; Scoliosis

Interventions: Diagnostic Test: mmWave Radar Gait Assessment

Sponsors: Gebze Technical University

Not yet recruiting

May 18, 2026

The Computerized Retraining and Functional Treatment – Group Intervention

Conditions: Cancer Related Cognitive Impairment; Breast Cancer Survivor

Interventions: Behavioral: CRAFT-G; Other: CCT

Sponsors: Hadassah Medical Organization; Israel Cancer Association; Hebrew University of Jerusalem

Recruiting

May 18, 2026

Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions: Drug: Experimental: Full-spectrum CBG oil 30 mg/mL; Drug: Placebo oil (MCT oil)

Sponsors: Universidade do Sul de Santa Catarina; Associação Brasileira de Cannabis Medicinal

Recruiting

May 18, 2026

Deep Brain Stimulation for Treatment-Resistant Schizophrenia

Conditions: Treatment Resistant Disorders

Interventions: Device: Medtronic Percept with SensSight Deep Brain Stimulation System

Sponsors: Johns Hopkins University

Not yet recruiting

May 18, 2026

NST-SPARK Open-Label Phase 1 STTR (IGNITE)

Conditions: Schizophrenia / Schizoaffective Disorder

Interventions: Device: NST-SPARK

Sponsors: North Shore Therapeutics, Inc.; Northwell Health; University of Pennsylvania

Not yet recruiting

May 18, 2026

Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia

Conditions: SCHIZOPHRENIA 1 (Disorder); Schizoaffecitve Disorder

Interventions: Behavioral: EEG Neurofeedback

Sponsors: University of California, San Diego

Not yet recruiting

May 18, 2026

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

Conditions: Major Depressive Disorder

Interventions: Other: Placebo; Drug: DT120

Sponsors: Definium Therapeutics US, Inc.

Recruiting

May 16, 2026

The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intentions Among Patients With Functional Neurological Movement Disorders

Conditions: Functional Neurological Disorder; Functional Movement Disorder

Interventions: Behavioral: Psychoeducational communication guide for first-diagnosis of FND

Sponsors: Medical University of Graz

Recruiting